No standalone psychedelic bill is introduced or advanced this quarter; any federal action appears only as a research/veterans rider on NDAA or appropriations by year-end.

Congress won't pass or even seriously debate a dedicated psychedelic drug bill before the end of 2026. The only way psychedelic policy moves at the federal level this year is if it gets quietly attached as a small add-on to a large military funding or government spending bill. This approach lets politicians support it without making it a public vote.

The empty docket confirms it. I can't get ahead of my district on a standalone vote. A rider is the only viable vehicle — bipartisan cover, low profile.